Belgium's advanced cancer diagnostics still behind the curve

EURACTIV - Belgium's precision oncology faces a critical gap in breast cancer care. Advanced diagnostics, including next-generation sequencing (NGS) are available, but the corresponding targeted therapies are not reimbursed. This disconnect is leaving many patients unable to fully benefit from the precision medicine potential. Read more

One of the most promising advancements in breast cancer diagnostics is the use of liquid biopsies.